Background and Aims Lipopolysaccharide binding protein (LBP) is involved in the modulation of acute liver injury and failure caused by acetaminophen (APAP). Although the biological activity of LBP is concentration dependent, little is known about its levels in acute liver failure. Methods Serum and hepatic LBP were measured in acute APAP-induced liver injury in mice. Serum LBP was measured in patients with acute liver failure from APAP and non-APAP causes. Results Interestingly, contrary to other diseases, serum and hepatic LBP levels decreased significantly in mice within 24 h after being subjected to APAP-induced injury compared to the control (1.6 ± 0.1 vs. 3.5 ± 1.6 lg/ml, respectively; P \ 0.05). Similar decreases were noted in another mouse model of acute liver injury due to carbon tetrachloride. Among patients with acute liver failure due to APAP (n = 5) and non-APAP (n = 5) causes, admission LBP levels were decreased compared to those of healthy controls (5.4 ± 1.4 vs. 3.2 ± 0.2 lg/ml, normal vs. acute liver failure; P = 0.07). However, the levels were not associated with the etiology of acute liver failure or 3-week outcome. Conclusions Serum and hepatic LBP levels are significantly reduced early after the induction of severe acute liver injury/failure due to acetaminophen and other liver injuries. This reduction in LBP production is specific to acute liver failure and may be important in developing future diagnostic and therapeutic approaches for patients with acute liver failure.
Introduction
Lipopolysaccharide binding protein (LBP) is an acute phase protein which plays an important role in lipopolysaccharide (LPS) signaling and innate immunity [1] [2] [3] .
LBP is a 60-kDa type I acute phase protein that is produced predominantly by hepatocytes [4, 5] . It is constitutively expressed and present in the serum at concentrations reported at 4-10 lg/ml using immunoassays, but can increase three-to tenfold after an acute phase response [6] . LBP binds with a high specificity and affinity (K d & 10 -9 ) to the lipid A portion of bacterial LPSs [7] to facilitate the transfer of LPS to cellular receptors, such as CD14. Early studies of LBP focused on its ability to augment LPS reactivity in monocytes [8] and Kupffer cells [9] . In the presence of LBP, 1/100th to 1/1,000th the concentration of LPS is needed to activate immune cells, which is consistent with the amount of LPS needed to cause immune activation in vivo. Therefore, LBP is considered to acts as an immune system sensitizer to help the cell detect and react to LPS and Gram-negative bacteria.
The ability of LBP to act as a sentinel for LPS detection is likely the mechanism by which it protects against Gramnegative infections. LBP has been shown to be protective in many different animal models of Gram-negative infections, including Klebsiella pneumonia [10, 11] and Salmonella peritonitis [12] . The increased susceptibility of LBP knockout (KO) mice to bacterial challenges and the ability of LBP repletion to correct these deficiencies support an important role for LBP in innate host immunity against common enteric pathogens [13] . In contrast to its protective role in bacterial infections, we found that LBP can be detrimental in acute liver injury caused by acetaminophen. Specifically, LBP KO mice were found to be protected against a lethal challenge of acetaminophen, and the administration of LBP inhibitory peptides protected mice from acetaminophen-induced liver injury [14, 15] The mechanism by which LBP participates in liver injury is not clear, but it is associated with a diminished hepatic inflammatory response. Although much emphasis has been focused on the ability of LBP to augment inflammatory response to LPS, it is clear that LBP can have either activating or inhibitory actions depending on its concentration [16] . At low concentrations, LBP augments activation by LPS, but at normal or high concentrations, LBP can actually inhibit LPS activation [17] . The level of LBP in acute liver injury and liver failure may significantly affect the physiological derangements that are observed in acute liver failure (ALF).
LBP levels have been studied in many clinical conditions, including sepsis, multi-organ failure, and acute pancreatitis [18, 19] . LBP levels are increased in these inflammatory states, and quantitative LBP levels have been proposed as a biomarker for infectious endocarditis and as a prognostic marker for patients with sepsis. In cirrhosis, LBP levels are also increased and associated with hyperdynamic circulation [20] . High LBP levels have also been found to be predictive of severe bacterial infections in cirrhotic patients with ascites [21] . However, only a limited number of studies have focused on the role of LBP in animal and human models of severe acute liver injury. The aims of our study were to measure and then to characterize the role of LBP in two well-described models of severe acute liver injury and failure, namely, that induced by acetaminophen (APAP) and carbon tetrachloride (CCL 4 ), respectively. We then set out to assess the role of LBP in human liver failure by measuring serum LBP levels from prospectively identified adult patients with acetaminophen-and non-acetaminopheninduced ALF. Contrary to our initial expectations, mouse serum LBP levels actually decreased after acute liver injury from acetaminophen, seemingly due to a reduction in LBP expression in the liver. In humans, we also confirmed a reduction in serum LBP levels in patients with ALF of varying etiology that was not related to the grade of encephalopathy or likelihood of recovery. These observations suggest that modulation of LBP expression may be of interest as a future therapeutic target in ALF.
Materials and Methods

Animal Models
For all experiments, male age-matched C57Bl/6 mice aged 8-14 weeks were used (Jackson Laboratories, Bar Harbor, ME). For the APAP-induced liver injury and failure, male mice were fasted for 16 h prior to administration of a single intra-peritoneal injection of either APAP (350 mg/kg in saline) or an equal volume of saline (Saline group). This protocol (injected dose after a 16-h fast) has previously been shown to lead to 100% mortality in this strain of mice by 72 h post-injection [15] . Mice were euthanized at either 6 or 24 h after the injection of APAP or 6 h after the injection of saline. For the CCl 4 -induced liver injury, mice were given a single intraperitoneal injection of CCl 4 (100 ll/kg diluted 1:10 in mineral oil) and euthanized at 1, 3, or 5 days after the injection. For the acute phase response model, mice were given a single hindlimb injection of turpentine (100 ll/ mouse) and sacrificed after 24 h. Control mice (CTRL) were untreated and sacrificed at 24 h. The experiments were performed in accordance with National Institute of Health guidelines, and prior approval was obtained from the University of Michigan Animal Care and Use Committee.
Human Study
Serum samples were obtained from adult patients with acute liver injury and failure due to acetaminophen (n = 5) and non-acetaminophen causes (n = 5) on day 1 after enrollment into the US Acute Liver Failure Study Group (ALFSG) at the University of Michigan. The ALFSG is a consortium of 23 referral centers with a research interest in Serum LBP, C-Reactive Protein, and Serum Amyloid P Levels Serum levels of LBP were determined using a commercially available enzyme-linked immunosorbent assay (ELISA) for the detection of mouse and human LBP per manufacturer's instructions (Cell Sciences, Canton, MA). Human serum C-reactive protein (CRP) levels were measured using the ELISA kit from Invitrogen (Carlsbad, CA). Mouse serum amyloid P (SAP) levels were measured using an ELISA kit from Kamiya Biomed (Seattle, WA).
Real Time Reverse Transcription PCR
Total liver RNA was isolated with the TRIzol reagent following the manufacturer's instructions (Invitrogen). Reverse transcription (RT) was performed as previously described [14] . To determine the relative amount of cytokine mRNA, the amplification of sample cDNA was monitored using the Smart Cycler (Cepheid, Sunnyvale, CA) and the DNA fluorescent dye SYBR Green (Molecular Probes, Eugene, OR). Primers were designed using reported sequences in Genbank: (1) LBP (5 0 -ACTTCAAG ATCAAGGCCGTGG and 3 0 -CACCGATGGAAGAGT CAGAGA); (2) actin (5 0 -TCTACG AGGGCTATGCTC TC and 3 0 -AAGAAGGAAGGCTGGAAAAG). The primers were designed to span at least one intron if possible to minimize the risk of genomic amplification. The specificity of the primers was verified by analyzing the PCR product of ethidium bromide-stained agarose gel electrophoresis as well as by direct sequencing of the PCR product. All real time PCR runs included a melting curve analysis to assure the specificity of the product with each PCR reaction. The validity of the semi-quantitative method is confirmed by a consistent log linear correlation of r 2 [ 0.95 between starting template RNA concentration and threshold cycle. All of the values were obtained by converting the threshold cycle of the sample to a relative RNA concentration based on the calibrator RNA (a random RNA sample generating a standard curve for that specific amplicon). All values are expressed as the ratio of RNA concentration of the target amplicon to the RNA concentration of the housekeeping gene (actin) to take into account different between-sample RNA concentrations.
Statistical Analysis
Analysis was performed using Statview software (SAS Institute, Cary, NC). Unless indicated otherwise, data are expressed as the mean ± standard error (SE). When two or more variables were compared, Student's t test and analysis of variance (ANOVA) with Fisher's PLSD post hoc analysis were used. Statistical significance was assigned at a P value \ 0.05.
Results
LBP Levels Are Decreased in a Mouse Model of APAP-Induced Liver Injury/Failure
Serum LBP levels were measured in C57/BL6 mice 6 and 24 h after being injected with a single dose of APAP (Fig. 1) . Our prior studies have shown that these conditions lead to ALF with peak liver injury by 6 h post-APAP injection [14] . Control animals were fasted in a similar fashion as the APAP mice, received an equal volume of saline by intraperitoneal injection (Saline group), and sacrificed at 6 h. Compared to the saline-injected mice, APAP-injected mice showed a significant decline in LBP level by 6 h post-injection, with the level remaining low at 24 h post-injection. Of note, the Fig. 1 Serum lipoppolysaccharide binding protein (LBP) levels at 6 and 24 h after injection with acetaminophen (APAP) or 6 h after injection of vehicle control (Saline). *P \ 0.05 compared to the LBP level in saline-injected mice, n = 4 per group levels of serum LBP in the saline-treated mice were similar to those of normal untreated mice (approximately 4 lg/ml, which is similar to that reported with this assay for normal mice levels [6] ). All mice died by day 3 after APAP injection, which is consistent with this being a model of ALF. In order to assess whether this unexpected decline in LBP levels during the acute phase following liver injury is unique to ATAP, we utilized a second animal model of hepatotoxicity that employed CCl 4 . In this model also, serum LBP levels were significantly lower on days 1 and 3 after the CCl 4 injection than in the serum of normal untreated mice (CTRL). However, by day 5 after the CCl 4 injection, the levels returned back to normal (Fig. 2) . The control mice were not fasted in this study since mice were not fasted prior to injection in the CCl 4 model.
To assure that the assay was accurate, we measured serum levels of LBP in a classic animal model of acute phase response [22] . In this model, we injected mice an intramuscular injection of turpentine (remote injury) and collected serum samples obtained 24 h after the insult. In contrast to the decline in LBP observed in mice with APAP-and CCl 4 -induced liver injury, serum LBP levels in the turpentine-injected mice increased by sevenfold, to 28 ± 2.1 lg/ml (n = 4 animals), 24 h after the injection. This is the anticipated level of rise for LBP after an acute phase response.
Steady State Hepatic LBP RNA Levels in APAPInduced Liver Failure
To determine if the decreased LBP levels observed in APAPinjected mice were due to a decline in hepatic LBP production, we examined the steady state RNA levels of LBP within the liver (Fig. 3) . Similar to the lower serum LBP levels, LBP RNA levels were significantly decreased by the 6-h timepoint after injection with APAP, with recovery by 24 h. This finding suggests that the decline in LBP levels was due to a decreased intrahepatic production of LBP.
LBP Levels Are Decreased in Patients with ALF
To further explore the role of LBP in human liver physiology, we examined ten patients from the ALFSG enrolled at the University of Michigan. As noted in Table 1 , there were five APAP hepatotoxicity patients (mean age 37 years) and five non-acetaminophen ALF patients (mean age 31 years). Of the ten patients, nine (90%) were female and nine (90%) were Caucasian. The female predominance noted here is consistent with prior reports demonstrating more female patients with ALF due to both APAP and non-APAP causes [23] . All patients with APAP-induced liver failure received N-acetyl cysteine prior to blood sampling, consistent with the standard of care, but only 40% of the non-APAP ALF patients received N-acetylcysteine, at the discretion of the clinical team. There was no distinct relationship discernable between the patient characteristics and LBP levels. However, there was a trend towards decreased levels in patients with ALF (P = 0.07) as compared to normal volunteers (CTRL) without any significant difference between APAP and non-APAP causes (Fig. 4) . In order to assess whether the decrease in LBP levels after ALF was specific for LBP or represented a general change in acute phase protein production, we measured the main acute phase proteins, CRP in humans and SAP in mice [24] . As noted in Fig. 5a , serum CRP levels increased significantly in patients with ALF due to both from APAP and non-APAP causes. Similarly, in mice, SAP significantly increased after acute APAP-induced liver injury (Fig. 5b) . Fig. 2 Serum LBP levels in mice on days 1, 3, and 5 after injection with carbon tetrachloride (CCl 4 ). *P \ 0.05 compared to the serum LBP level in untreated mice (CTRL), n = 3 per group Fig. 3 Relative LBP RNA levels in the liver of mice 6 and 24 h after injection with APAP or 6 h after injection with saline (Saline). *P \ 0.05 compared to the LBP RNA levels in saline-injected mice, n = 4-9 per group Dig Dis Sci (2012) 57:918-924 921
Discussion
Unlike other disease states where LBP levels are typically elevated, we found that LBP levels were lower in ALF patients than in healthy volunteers. This decrease in serum LBP levels was associated with a reduction in steady state intrahepatic RNA levels, suggesting diminished hepatic production. In mice, similar reductions in LBP levels were also seen in a second toxic model of liver injury, CCl 4 . By contrast, in the acute phase model of intramuscular turpentine, LBP levels increased more than sevenfold, consistent with what has been seen clinically in other inflammatory states, such as infections, sepsis, acute pancreatitis, and Crohn's disease [18, 19, [25] [26] [27] . In fact, there have been many specific situations, such as cirrhosis, renal transplantation, and neonates, where increased LBP may be a predictor for the presence of bacterial infection [21, [28] [29] [30] .
In our study, we found that LBP trended downward in ALF due to multiple causes. In our study, there was no clear difference in the levels between different causes of ALF (whether APAP or non-APAP), but the number of patients studied was limited. Our observations are in contrast to other types of chronic liver disease, including biliary obstruction and cirrhosis, where LBP levels have been reported to increase [20, 31, 32] .
The decrease in LBP level in ALF that we observed is surprising. Generally, fulminant hepatic failure is associated with an acute phase response. Levels of acute phase reactants, such as CRP, and pro-inflammatory cytokines, such as interleukin-6 (IL-6) are increased in ALF [33] . Similar to CRP, LBP production is up-regulated by IL-6 as well as by other pro-inflammatory cytokines [34] . In most inflammatory states, such as sepsis and multiple organ dysfunction syndrome (MODS), both LBP and CRP are increased [26, 35] .
The clinical significance of the decrease in LBP levels is not known. However, it is important to note that the levels detected in ALF (2-3 lg/ml) are sufficient for activating LBP. In fact, very low concentrations of LBP are required for the activation of LPS, which is in contrast to the inhibitory properties. In virtually all of the in vitro studies that have been reported on LBP-activating properties, the doses of LBP utilized ranged between 1 and 5% serum [1] . In contrast, high levels of LBP, as seen in sepsis, may actually have an inhibitory action on LPS activation [16, 36] . In ex vivo studies, sera from patients with systemic inflammatory response syndrome had inhibited LPS activation of human monocytes. Studies using LBP depletion and the addition of recombinant LBP confirmed that the critical factor responsible for inhibiting LPS activation was high levels of LBP [16] . Results from biophysical studies suggest that intercalation of LBP into the membrane may be important for LBPmediated activation, while LBP-LPS complexation in serum may lead to neutralization, providing a potential mechanism for this disparate concentration-dependent role of LBP [36] . The dual role of LBP was confirmed with in vivo studies by Lamping et al. [17] who showed that the administration of high doses of LBP was protective in mouse model of sepsis. Similar to monocytes, the effect of LBP on LPS activation of Kupffer cells is also dose-dependent [32] . Furthermore, we found that the concentration of LBP determining whether LBP was activating of inhibitory depended on the responding cell. Thus, Kupffer cells, which were activated, required more LBP to inhibit LPS activation than a resting Kupffer cell. Activated Kupffer cells isolated from animals with biliary obstruction required significantly higher concentrations of LBP to inhibit LPS-mediated activation than sham animals [32] . Thus, we speculate that in ALF, the low concentrations of LBP that are present enhance LPS activation and thus can contribute to the overall hyper-inflammatory state typically seen in this clinical setting. As such, restoration or supplementation of LBP in this state may be potentially therapeutic and will require further study. 
